'Developing a new drug is stumbling in the dark without a map. We are building the GPS'

22 mai 2022 | Sagi Cohen
When Immunai, a machine learning firm creating a ‘GPS’ for drug development, was just getting started a leading professor was skeptical about it – now he's their close consultant
 Site référencé:  Haaretz

Haaretz 

United Arab Emirates confirms first case of monkeypox
24/05/2022
Israel's Health Ministry to probe violence during slain Al Jazeera journalist's funeral
24/05/2022
Israel launched only one criminal probe into Palestinian casualties in last Gaza war
24/05/2022
Progressive Jews urge ADL chief to apologize for calling out Democratic activist
24/05/2022
In Jordan, the antisemitism is undisguised, and everywhere
24/05/2022
'Make drones, not porn' : Top Israeli defense firm seeks moral high ground over tech industry
24/05/2022